Supplementary Table S1 from Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion–Defined Rhabdomyosarcoma
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S1 shows the agents used for in vitro drug sensitivity and synergy studies.
创建时间：
2025-12-02
